PROCAR
Dead / Abandoned — Abandoned — no statement of use filed (as of 03 Oct 2022)
What this means for you
This application is over — abandoned 03 Oct 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88168274
- Mark type
- Stylized text
- Filed
- 24 Oct 2018
- Published for opposition
- 02 Jul 2019
- Abandoned
- 03 Oct 2022
- Attorney of record
- Christine K. Au-Yeung
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for T Cell therapy; pharmaceutical products for the prevention and treatment of cancer; immunotherapy products, namely, pharmaceutical preparations for the treatment of cancer and tumors; biological preparations for the treatment of cancer and tumors; biotechnological platform technology, namely, biotechnological, diagnostic, and therapeutic preparations in the form of antibodies for delivery to cells in T cell therapy and treatment of cancer
- Class 042 — Scientific and technological services: Pharmaceutical research and development
Owner
- Harpoon Therapeutics, Inc., South San Francisco, CA, US
- Harpoon Therapeutics, Inc., South San Francisco, CA, US
Prosecution history
- 03 Oct 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 03 Oct 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 10 Feb 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Feb 2022 — SOU EXTENSION 5 GRANTED
- 02 Feb 2022 — SOU EXTENSION 5 FILED
- 09 Feb 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 02 Feb 2022 — SOU TEAS EXTENSION RECEIVED
- 12 Aug 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Aug 2021 — SOU EXTENSION 4 GRANTED
- 10 Aug 2021 — SOU EXTENSION 4 FILED
- 10 Aug 2021 — SOU TEAS EXTENSION RECEIVED
- 04 Feb 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Feb 2021 — SOU EXTENSION 3 GRANTED
- 02 Feb 2021 — SOU EXTENSION 3 FILED
- 02 Feb 2021 — SOU TEAS EXTENSION RECEIVED